OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
WALTHAM, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq:OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that executives from the Company will be presenting and participating in one-on-ones at the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA from January 8-11, 2024.
Related news for (OPRX)
- OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
- OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
- OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
- OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
- Today’s Top Performers: MoBot’s Market Review 03/12/25 09:00 AM